Variant report
Variant | rs199514 |
---|---|
Chromosome Location | chr17:44856881-44856882 |
allele | A/G |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:44854147..44858809-chr17:44869558..44873940,6 | K562 | blood: | |
2 | chr17:44855566..44859051-chr17:44896605..44899961,3 | K562 | blood: | |
3 | chr17:44848371..44851556-chr17:44854343..44857073,3 | MCF-7 | breast: | |
4 | chr17:44854870..44856940-chr17:44861848..44864118,2 | K562 | blood: | |
5 | chr17:44791299..44793121-chr17:44854894..44857732,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
rs_ID | r2[population] |
---|---|
rs1378358 | 1.00[ASN][1000 genomes] |
rs142167 | 0.84[CEU][hapmap] |
rs169201 | 0.94[CEU][hapmap];0.84[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs183211 | 0.84[CEU][hapmap] |
rs199436 | 0.84[CEU][hapmap] |
rs199438 | 0.84[CEU][hapmap] |
rs199439 | 0.94[CEU][hapmap];0.86[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs199442 | 0.84[CEU][hapmap] |
rs199443 | 0.94[CEU][hapmap];0.90[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs199444 | 0.84[CEU][hapmap] |
rs199445 | 0.94[CEU][hapmap];0.90[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs199447 | 0.89[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs199448 | 0.94[CEU][hapmap];0.89[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs199449 | 0.84[CEU][hapmap] |
rs199451 | 0.94[CEU][hapmap];0.86[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs199452 | 0.84[CEU][hapmap] |
rs199453 | 0.84[CEU][hapmap] |
rs199454 | 0.84[CEU][hapmap] |
rs199455 | 0.90[CEU][hapmap] |
rs199456 | 0.94[CEU][hapmap];0.86[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs199457 | 0.94[CEU][hapmap];0.86[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs199498 | 0.94[CEU][hapmap] |
rs199499 | 0.81[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs199501 | 0.89[CEU][hapmap] |
rs199502 | 0.86[EUR][1000 genomes] |
rs199503 | 0.88[AMR][1000 genomes];0.96[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs199504 | 1.00[CEU][hapmap];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs199505 | 1.00[CEU][hapmap];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs199506 | 1.00[CEU][hapmap];1.00[YRI][hapmap];0.95[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs199507 | 1.00[CEU][hapmap];1.00[YRI][hapmap];0.95[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs199509 | 1.00[CEU][hapmap];1.00[YRI][hapmap];0.95[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs199510 | 0.86[AMR][1000 genomes];0.90[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs199512 | 1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs199513 | 1.00[CEU][hapmap];1.00[YRI][hapmap];0.95[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs199515 | 1.00[CEU][hapmap];0.92[YRI][hapmap];0.95[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs199516 | 1.00[CEU][hapmap];0.93[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes] |
rs199520 | 0.88[CEU][hapmap] |
rs199524 | 0.90[CEU][hapmap] |
rs199525 | 0.93[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs199526 | 0.87[EUR][1000 genomes] |
rs199528 | 1.00[CEU][hapmap];0.93[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs199529 | 0.82[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs199533 | 0.94[CEU][hapmap];0.92[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs199534 | 0.94[CEU][hapmap];0.90[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs199535 | 0.94[CEU][hapmap];0.90[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs199536 | 0.84[CEU][hapmap] |
rs415430 | 1.00[CEU][hapmap];1.00[YRI][hapmap];0.91[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs430685 | 0.91[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs538628 | 1.00[CEU][hapmap];1.00[ASN][1000 genomes] |
rs70600 | 0.96[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs70602 | 1.00[CEU][hapmap];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes] |
rs916888 | 1.00[ASN][1000 genomes] |
rs9896243 | 0.94[CEU][hapmap];0.89[EUR][1000 genomes];1.00[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv431716 | chr17:43893020-44868187 | Strong transcription Weak transcription Enhancers Active TSS Flanking Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 62 gene(s) | inside rSNPs | diseases |
2 | nsv431718 | chr17:44094463-44873614 | Weak transcription Strong transcription Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS ZNF genes & repeats Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 55 gene(s) | inside rSNPs | diseases |
3 | nsv431729 | chr17:44144214-44869063 | Enhancers Weak transcription Flanking Active TSS Active TSS Strong transcription Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 54 gene(s) | inside rSNPs | diseases |
4 | esv2757660 | chr17:44162284-44868187 | Enhancers Genic enhancers ZNF genes & repeats Weak transcription Active TSS Flanking Active TSS Strong transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 54 gene(s) | inside rSNPs | diseases |
5 | nsv431805 | chr17:44165803-44868430 | Weak transcription Enhancers Active TSS Bivalent Enhancer Strong transcription Genic enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 54 gene(s) | inside rSNPs | diseases |
6 | esv3492820 | chr17:44174959-45161556 | Weak transcription Strong transcription Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent/Poised TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 73 gene(s) | inside rSNPs | diseases |
7 | esv3492821 | chr17:44174959-45161556 | Weak transcription Genic enhancers Enhancers Bivalent Enhancer Strong transcription Flanking Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 73 gene(s) | inside rSNPs | diseases |
8 | nsv916432 | chr17:44223908-44873614 | Enhancers Weak transcription Active TSS Strong transcription ZNF genes & repeats Genic enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 54 gene(s) | inside rSNPs | diseases |
9 | esv3502492 | chr17:44305975-45169159 | Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Bivalent/Poised TSS Weak transcription Genic enhancers ZNF genes & repeats Strong transcription Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 54 gene(s) | inside rSNPs | diseases |
10 | esv3502493 | chr17:44305975-45169159 | Active TSS Weak transcription Flanking Active TSS Strong transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Bivalent/Poised TSS ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 54 gene(s) | inside rSNPs | diseases |
11 | esv1819056 | chr17:44391822-44873614 | Enhancers Strong transcription Active TSS Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Genic enhancers Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 23 gene(s) | inside rSNPs | diseases |
12 | esv1844763 | chr17:44391822-44913631 | Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Enhancers ZNF genes & repeats Bivalent Enhancer Strong transcription Active TSS Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 24 gene(s) | inside rSNPs | diseases |
13 | nsv428343 | chr17:44391822-44913631 | Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Enhancers Weak transcription Strong transcription Active TSS Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 24 gene(s) | inside rSNPs | diseases |
14 | esv1806073 | chr17:44443111-44873614 | Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 22 gene(s) | inside rSNPs | diseases |
15 | nsv531823 | chr17:44485771-45067769 | Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Strong transcription Bivalent/Poised TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 30 gene(s) | inside rSNPs | diseases |
16 | esv1850605 | chr17:44537030-44913631 | Weak transcription Genic enhancers Enhancers Flanking Bivalent TSS/Enh Strong transcription Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 21 gene(s) | inside rSNPs | diseases |
17 | esv1818944 | chr17:44662268-44859144 | Genic enhancers Weak transcription Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Strong transcription Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 14 gene(s) | inside rSNPs | diseases |
18 | esv1803756 | chr17:44680207-44865439 | Strong transcription Weak transcription Enhancers Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS ZNF genes & repeats Bivalent/Poised TSS Flanking Active TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 14 gene(s) | inside rSNPs | diseases |
19 | nsv833465 | chr17:44706496-44889749 | Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Genic enhancers Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 15 gene(s) | inside rSNPs | diseases |
20 | esv1843460 | chr17:44732200-44913631 | Bivalent Enhancer Enhancers Flanking Active TSS Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Active TSS Weak transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 16 gene(s) | inside rSNPs | diseases |
21 | nsv908562 | chr17:44828931-45102413 | Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Weak transcription Strong transcription Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 26 gene(s) | inside rSNPs | diseases |
22 | nsv949295 | chr17:44836653-45080757 | Weak transcription Bivalent Enhancer Enhancers Strong transcription Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA | 24 gene(s) | inside rSNPs | diseases |
23 | esv1807468 | chr17:44848517-44865439 | Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS Genic enhancers Strong transcription | Chromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
SNP | Gene | Cis/trans | Tissue | Source |
---|---|---|---|---|
rs199514 | RP11-259G18.3 | cis | Artery Aorta | GTEx |
rs199514 | KANSL1-AS1 | cis | Whole Blood | GTEx |
rs199514 | LRRC37A17P | cis | Esophagus Mucosa | GTEx |
rs199514 | KANSL1-AS1 | cis | Stomach | GTEx |
rs199514 | MAPT | cis | Frontal Cortex | GTEx |
rs199514 | LOC644246///LOC649063 | cis | normal skin | skin_eQTL |
rs199514 | RP11-259G18.3 | cis | Muscle Skeletal | GTEx |
rs199514 | RP11-259G18.2 | cis | Thyroid | GTEx |
rs199514 | LRRC37A2 | cis | Artery Aorta | GTEx |
rs199514 | LRRC37A2 | cis | Esophagus Muscularis | GTEx |
rs199514 | RP11-259G18.3 | cis | Esophagus Muscularis | GTEx |
rs199514 | LRRC37A2 | cis | Esophagus Mucosa | GTEx |
rs199514 | LRRC37A2 | cis | Muscle Skeletal | GTEx |
rs199514 | RP11-259G18.2 | cis | lung | GTEx |
rs199514 | KANSL1-AS1 | cis | Skin Sun Exposed Lower leg | GTEx |
rs199514 | LRRC37A2 | cis | Nerve Tibial | GTEx |
rs199514 | LRRC37A | cis | Artery Aorta | GTEx |
rs199514 | LRRC37A | cis | Frontal Cortex | GTEx |
rs199514 | LRRC37A2 | cis | Adipose Subcutaneous | GTEx |
rs199514 | KANSL1-AS1 | cis | Esophagus Mucosa | GTEx |
rs199514 | LRRC37A | cis | Esophagus Muscularis | GTEx |
rs199514 | KANSL1-AS1 | cis | Heart Left Ventricle | GTEx |
rs199514 | LRRC37A2 | cis | Skin Sun Exposed Lower leg | GTEx |
rs199514 | RP11-259G18.2 | cis | Skin Sun Exposed Lower leg | GTEx |
rs199514 | MAPK8IP1 | cis | Cerebellum | GTEx |
rs199514 | LRRC37A2 | cis | Whole Blood | GTEx |
rs199514 | LRRC37A | cis | Thyroid | GTEx |
rs199514 | RP11-259G18.3 | cis | Whole Blood | GTEx |
rs199514 | KANSL1-AS1 | cis | lung | GTEx |
rs199514 | MAPK8IP1 | trans | lymphoblastoid | RTeQTL |
rs199514 | LRRC37A2 | cis | lung | GTEx |
rs199514 | LRRC37A2 | cis | Artery Tibial | GTEx |
rs199514 | LRRC37A4 | Cis_chr | lymphoblastoid | RTeQTL |
rs199514 | RP11-259G18.2 | cis | Nerve Tibial | GTEx |
rs199514 | KIAA1267 | cis | normal skin | skin_eQTL |
rs199514 | KANSL1-AS1 | cis | Artery Tibial | GTEx |
rs199514 | RP11-259G18.2 | cis | Stomach | GTEx |
rs199514 | WNT3 | cis | Thyroid | GTEx |
rs199514 | ARL17 | Cis_1M | lymphoblastoid | RTeQTL |
rs199514 | KANSL1-AS1 | cis | Muscle Skeletal | GTEx |
rs199514 | LOC644246 | cis | uninvolved skin | skin_eQTL |
rs199514 | RP11-259G18.3 | cis | Nerve Tibial | GTEx |
rs199514 | KIAA1267 | cis | uninvolved skin | skin_eQTL |
rs199514 | RP11-259G18.3 | cis | Heart Left Ventricle | GTEx |
rs199514 | LRRC37A2 | cis | Stomach | GTEx |
rs199514 | RP11-259G18.3 | cis | Esophagus Mucosa | GTEx |
rs199514 | RP11-259G18.3 | cis | Artery Tibial | GTEx |
rs199514 | RP11-259G18.2 | cis | Muscle Skeletal | GTEx |
rs199514 | LOC644246///LOC649063 | cis | lesional skin | skin_eQTL |
rs199514 | KIAA1267 | cis | lesional skin | skin_eQTL |
rs199514 | RP11-259G18.3 | cis | Stomach | GTEx |
rs199514 | LRRC37A | cis | Nerve Tibial | GTEx |
rs199514 | RP11-259G18.2 | cis | Heart Left Ventricle | GTEx |
rs199514 | RP11-259G18.2 | cis | Esophagus Muscularis | GTEx |
rs199514 | LRRC37A | cis | Artery Tibial | GTEx |
rs199514 | MAPT | cis | Cerebellum | GTEx |
rs199514 | KANSL1-AS1 | cis | Adipose Subcutaneous | GTEx |
rs199514 | LRRC37A | cis | Stomach | GTEx |
rs199514 | RP11-259G18.2 | cis | Adipose Subcutaneous | GTEx |
rs199514 | KANSL1-AS1 | cis | Nerve Tibial | GTEx |
rs199514 | RP11-259G18.3 | cis | lung | GTEx |
rs199514 | LOC644246///LOC649063 | cis | uninvolved skin | skin_eQTL |
rs199514 | RP11-259G18.3 | cis | Thyroid | GTEx |
rs199514 | KANSL1-AS1 | cis | Artery Aorta | GTEx |
rs199514 | RP11-259G18.2 | cis | Whole Blood | GTEx |
rs199514 | RP11-259G18.3 | cis | Adipose Subcutaneous | GTEx |
rs199514 | LRRC37A2 | cis | Thyroid | GTEx |
rs199514 | RP11-259G18.2 | cis | Esophagus Mucosa | GTEx |
rs199514 | RP11-259G18.2 | cis | Artery Aorta | GTEx |
rs199514 | LOC644246 | Cis_1M | lymphoblastoid | RTeQTL |
rs199514 | KANSL1-AS1 | cis | Esophagus Muscularis | GTEx |
rs199514 | LRRC37A | cis | Adipose Subcutaneous | GTEx |
rs199514 | LRRC37A | cis | lung | GTEx |
rs199514 | RP11-259G18.2 | cis | Artery Tibial | GTEx |
rs199514 | RP11-259G18.3 | cis | Skin Sun Exposed Lower leg | GTEx |
rs199514 | KANSL1-AS1 | cis | Thyroid | GTEx |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:44850000-44862800 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
2 | chr17:44854800-44857000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
3 | chr17:44854800-44859400 | Weak transcription | Primary B cells from peripheral blood | blood |
4 | chr17:44855200-44857000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr17:44855200-44857000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr17:44855600-44859200 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
7 | chr17:44855800-44857200 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
8 | chr17:44855800-44857600 | Bivalent Enhancer | Fetal Muscle Leg | muscle |
9 | chr17:44855800-44862600 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr17:44856000-44857000 | Enhancers | HSMMtube | muscle |
11 | chr17:44856200-44857000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
12 | chr17:44856200-44857200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr17:44856200-44857400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
14 | chr17:44856600-44857200 | Bivalent Enhancer | Skeletal Muscle Male | skeletal muscle |
15 | chr17:44856800-44857000 | Bivalent Enhancer | H1 Cell Line | embryonic stem cell |
16 | chr17:44856800-44857000 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
17 | chr17:44856800-44857000 | Bivalent Enhancer | Skeletal Muscle Female | skeletal muscle |
18 | chr17:44856800-44857200 | Active TSS | Spleen | Spleen |
19 | chr17:44856800-44857600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
20 | chr17:44856800-44857600 | Flanking Active TSS | K562 | blood |
21 | chr17:44856800-44857800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
22 | chr17:44856800-44857800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
23 | chr17:44856800-44859400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
24 | chr17:44856800-44861000 | Weak transcription | Placenta | Placenta |